文献速递儿童心血管与肾脏新生儿儿童内分泌与遗传代谢

先天性心脏手术对13三体和18三体住院死亡率的影响

Congenital Heart Surgery on In-Hospital Mortality in Trisomy 13 and 18.
PubMed 文献 · Pediatrics · 2017-10-18

基于2004至2015年儿科健康信息系统数据库,纳入≤14天龄的18三体婴儿1020例和13三体婴儿648例,比较有无先天性心脏病及是否接受先天性心脏手术的住院死亡率。

要点

  • 18三体和13三体婴儿中先天性心脏病常见(分别91%和86%),但仅7%接受心脏手术。
  • 接受先天性心脏手术与18三体住院死亡率降低64%、13三体降低45%相关。
  • 手术组死亡率降低在24个月随访期间持续存在。

核心结论

  • 先天性心脏手术与18三体和13三体婴儿住院死亡率降低相关。
  • 结果提示在特定病例中先天性心脏手术可能有益。

研究设计与样本

  • 回顾性队列研究,使用2004至2015年儿科健康信息系统数据库。
  • 纳入≤14天龄的18三体婴儿1020例和13三体婴儿648例。
  • 分析再入院以评估较长时期住院死亡率。

主要发现

  • 18三体婴儿中91%存在先天性心脏病,13三体中86%。
  • 每组7%的婴儿接受了先天性心脏手术。
  • 死亡率降低在24个月随访期间持续存在。
  • 较高体重、女性和入院时年龄较大与住院死亡率降低相关。

临床怎么用

  • 对于18三体和13三体婴儿,先天性心脏手术可作为选择性病例的考虑选项。
  • 评估手术获益时需结合体重、性别和入院年龄等因素。

局限性

  • 回顾性数据库研究,可能存在选择偏倚和混杂因素。
  • 仅纳入≤14天龄新生儿,结论外推需谨慎。
  • 未报告手术具体类型和指征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Congenital heart disease (CHD) is common in trisomy 13 (T13) and trisomy 18 (T18), but surgical repair has not been offered in most centers. Data on outcomes of congenital heart surgery (CHS) for T13 and T18 are lacking. We sought to determine the impact of CHS on in-hospital mortality in T13 and T18. METHODS: Data from the 2004 to 2015 Pediatric Health Information System database were used to identify inpatients with T13 or T18 and CHD. Data were restricted to newborns with T13 or T18 admitted at ≤14 days of age. Hospital readmissions were examined to analyze longer-term in-hospital mortality. In-hospital mortality and length of stay were compared between infants with and without CHD and with and without CHS. RESULTS: The study cohort included 1020 infants with T18 and 648 infants with T13. CHD was present in 91% of infants with T18 and 86% of infants with T13. CHS was performed in 7% of each group. In-hospital mortality was decreased in those who underwent CHS (64% lower in T18 [P <.001]; 45% lower in T13 [P = .003]) and remained decreased throughout the 24 months of follow-up. In-hospital mortality was decreased in infants with higher weight, female sex, and older age at admission. CONCLUSIONS: CHS is associated with decreased in-hospital mortality in T18 and T13. These results suggest CHS may be beneficial in select cases.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Kosiv KA, Gossett JM, Bai S, et al. Congenital Heart Surgery on In-Hospital Mortality in Trisomy 13 and 18. Pediatrics. 2017. PMID: 29046387. doi:10.1542/peds.2017-0772

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。